| Financial Year |
March 31 2023 |
| Monetary Funds |
399,282,003.62 |
| Held-for-trading Financial Assets |
370,000,000.00 |
| Notes Receivable |
21,997,085.85 |
| Accounts Receivable |
101,758,991.51 |
| Advances to Suppliers |
19,908,619.65 |
| Other Receivables |
1,103,588.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
84,143,743.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,038,183,973.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,864,720.20 |
| Fixed Assetes |
81,196,522.02 |
| Under-construction Projects |
796,460.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,935,420.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,024,253.69 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
92,127,490.35 |
| Total Assets |
1,130,311,463.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,731,522.35 |
| Accounts Payable |
6,920,991.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,862,222.45 |
| Taxes Payable |
6,452,114.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,399,976.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
303,066.08 |
| Other Current Liabilities |
1,078,793.11 |
| Sub-Total of Current Liabilities |
56,044,422.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,865,152.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,901,011.97 |
| Total Liabilities |
66,945,434.62 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
625,735,868.01 |
| Surplus Reserve |
39,307,240.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
278,322,921.21 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,063,366,029.31 |
| Owner's Equity（Stockholder's Equity） |
1,063,366,029.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,130,311,463.93 |
